2m 2m 2m 2m 2m 2m 2m
- $497.00Market Cap
- 0.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
OWC Pharm Resear (OWCP)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 50
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 05/29/2026
Company Profile
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.
Key Executives
- Yehuda Baruch
- Alon Sinai
- Shmuel De-Saban
- Ziv Turner
- Yuval Ramot
Current Ownership Distribution
- Other425.2M (85.48%)
- Insiders72.2M (14.52%)
- Institutions25,000 (0.005%)
- Mutual Funds0 (0.00%)